RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysisHongli Yu, Qiang Zhu, Yuping Bai et al.|BMJ Open|2022Cited by 42
Comparison of the diagnostic efficacy between two PCR test kits for SARS‐CoV‐2 nucleic acid detectionYu Lu, Hongli Yu|Journal of Clinical Laboratory Analysis|2020Cited by 39
Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysisYang Yao, Qiang Zhu, Yajing You et al.|International Journal of Hyperthermia|2021Cited by 27
Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysisYang Yao, Qiang Zhu, Hongli Yu et al.|International Journal of Hyperthermia|2022Cited by 26
Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma in patients with decompensated cirrhosisHongli Yu, Hang Zheng, Qiang Zhu et al.|HPB|2024Cited by 3